Simone Borgoni

6PUBLICATIONS
55CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Jul 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee

|May 04, 2021
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors.

Yuya Haga, Ilaria Marrocco, Ashish Noronha

|Dec 15, 2020
Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks.

Kevin Ho Wai Yim, Ala'a Al Hrout, Simone Borgoni

|Oct 14, 2020
Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer.

Simone Borgoni, Emre Sofyalı, Maryam Soleimani

Pageof 1

Frequent Collaborators

5 joint publications

Stefan Wiemann

4 joint publications

Rainer Will

4 joint publications

Nishanth Belugali Nataraj

3 joint publications

Yosef Yarden